IMM‐H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high‐fat diet

Nonalcoholic fatty liver disease (NAFLD), the most common chronic liver disease in humans, is characterized by the accumulation of triacylglycerols (TGs) in hepatocytes. We tested whether 2′,3′,5′‐tri‐acetyl‐N6‐(3‐hydroxylaniline) adenosine (IMM‐H007) can eliminate hepatic steatosis in hamsters fed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Huijie, Wang, Qingchun, Yang, Liu, Xie, Shouxia, Zhu, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586352/
https://www.ncbi.nlm.nih.gov/pubmed/28904866
http://dx.doi.org/10.1002/2211-5463.12272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586352/
https://www.ncbi.nlm.nih.gov/pubmed/28904866
http://dx.doi.org/10.1002/2211-5463.12272

Ejemplares similares